Springfield Properties PLC Exercise of Options, Issue of Equity and TVR

RNS Number : 6553H

Springfield Properties PLC

20 March 2024

 

20 March 2024

 

Springfield Properties plc

("Springfield" or the "Company")

 

Exercise of Options, Issue of Equity and Total Voting Rights

 

Springfield Properties plc (AIM: SPR), a leading housebuilder in Scotland focused on delivering private and affordable housing, announces that, on 15 March 2024, an employee of the Company exercised options over 13,748 ordinary shares of 0.125 pence each in the Company ("Ordinary Shares").

 

Total Voting Rights

Application has been made to the London Stock Exchange for the 13,748 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective at 8:00 a.m. on or around 26 March 2024. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in the Company. 

Following Admission, the total number of Ordinary Shares in issue will be 118,669,124. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries

 

Springfield Properties
Sandy Adam, Chairman Innes Smith, Chief Executive Officer Iain Logan, Chief Financial Officer	[phone]
Singer Capital Markets
Shaun Dobson, James Moat, Oliver Platts (Investment Banking)	[phone]
Gracechurch Group
Harry Chathli, Claire Norbury, Henry Gamble	[phone]

 

Analyst Research

 

Equity Development and Progressive Equity produce freely available research on Springfield Properties plc, including financial forecasts. This is available to view and download here:

https://www.thespringfieldgroup.co.uk/news/updates-and-analyst-reports

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEQKKBPQBKDONB